Green Planet Bioengineering Co. Ltd. (GPLB) financial statements (2020 and earlier)
Company profile
| Business Address |
20807 BISCAYNE BLVD. AVENTURA, FL 33180 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| SIC | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Noncurrent Assets | |||||||||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 0 | 12 | 12 | 12 | 11 | ||||
| Accounts payable | 0 | ||||||||
| Accrued liabilities | 12 | 12 | 12 | 11 | |||||
| Due to related parties | 283 | 246 | 206 | 172 | 136 | 102 | 54 | ||
| Total current liabilities: | 283 | 258 | 217 | 183 | 148 | 102 | 54 | ||
| Noncurrent Liabilities | |||||||||
| Other undisclosed liabilities | 13 | 23 | |||||||
| Total liabilities: | 283 | 258 | 217 | 183 | 148 | 115 | 77 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | (283) | (258) | (217) | (183) | (148) | (115) | (77) | ||
| Common stock | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||
| Additional paid in capital | 610 | 610 | 610 | 610 | 610 | 610 | 610 | ||
| Accumulated deficit | (912) | (887) | (847) | (813) | (777) | (744) | (707) | ||
| Other undisclosed stockholders' equity attributable to parent | 0 | ||||||||
| Total stockholders' equity: | (283) | (258) | (217) | (183) | (148) | (115) | (77) | ||
Income statement (P&L) ($ in thousands)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Operating expenses | (25) | (40) | (34) | (36) | (33) | (38) | (34) | |
| Operating loss: | (25) | (40) | (34) | (36) | (33) | (38) | (34) | |
| Loss before gain (loss) on sale of properties: | (25) | (40) | (34) | (36) | (33) | (38) | (34) | |
| Other undisclosed net income | 89 | 49 | 45 | 48 | 44 | 50 | 46 | |
| Net income: | 64 | 8 | 12 | 12 | 11 | 13 | 12 | |
| Other undisclosed net loss attributable to parent | (89) | (49) | (45) | (48) | (44) | (50) | (46) | |
| Net loss available to common stockholders, diluted: | (25) | (40) | (34) | (36) | (33) | (38) | (34) | |
Comprehensive Income ($ in thousands)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 64 | 8 | 12 | 12 | 11 | 13 | 12 | |
| Comprehensive income, net of tax, attributable to parent: | 64 | 8 | 12 | 12 | 11 | 13 | 12 | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.